| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Frederik H Verbrugge | Q57161450 |
| P2093 | author name string | W H Wilson Tang | |
| Stanley L Hazen | |||
| P2860 | cites work | Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway. | Q53583788 |
| Carbamylation-induced alterations in low-density lipoprotein metabolism | Q67490684 | ||
| Carbamylation of insulin and its biological activity | Q68164263 | ||
| Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein | Q72524347 | ||
| Carbamylated hemoglobin in hemodialysis patients | Q73686578 | ||
| Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils | Q82623788 | ||
| Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis | Q24629328 | ||
| Inhibition of erythropoietin activity by cyanate. | Q30341904 | ||
| Protein carbamylation links inflammation, smoking, uremia and atherogenesis. | Q30364367 | ||
| Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes | Q30429333 | ||
| Carbamoylation of amino acids and proteins in uremia | Q31905731 | ||
| Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro | Q33852491 | ||
| Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions | Q34236265 | ||
| Prognostic value of myeloperoxidase in patients with chest pain | Q34271813 | ||
| Uremia alters HDL composition and function | Q35210194 | ||
| The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients | Q35748662 | ||
| Protein carbamylation renders high-density lipoprotein dysfunctional | Q36050583 | ||
| Protein carbamylation predicts mortality in ESRD. | Q36796565 | ||
| Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure | Q36971450 | ||
| 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima | Q37366288 | ||
| An abundant dysfunctional apolipoprotein A1 in human atheroma | Q37581580 | ||
| Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. | Q41541678 | ||
| The urea decomposition product cyanate promotes endothelial dysfunction | Q42025075 | ||
| In vitro inhibition of low density lipoprotein carbamylation by vitamins, as an ameliorating atherosclerotic risk in uremic patients | Q43161877 | ||
| Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis | Q44895729 | ||
| Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. | Q46563174 | ||
| Carbamylated low-density lipoprotein induces endothelial dysfunction | Q46915576 | ||
| Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau. | Q48790501 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | artery | Q9655 |
| cardiovascular disease | Q389735 | ||
| post-translational protein modification | Q898362 | ||
| protein carbonylation | Q70711142 | ||
| P304 | page(s) | 474-478 | |
| P577 | publication date | 2015-06-10 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Protein carbamylation and cardiovascular disease | |
| P478 | volume | 88 |
| Q93007015 | Carbamoylated Nail Proteins as Assessed by Near-Infrared Analysis are Associated with Load of Uremic Toxins and Mortality in Hemodialysis Patients |
| Q42616697 | Carbamylated Low-Density Lipoprotein and Thrombotic Risk in Chronic Kidney Disease |
| Q47732797 | Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden? |
| Q50515107 | Comparison of air samplers for determination of isocyanic acid and applicability for work environment exposure assessment. |
| Q93155715 | Cyanate Induces Oxidative Stress Injury and Abnormal Lipid Metabolism in Liver through Nrf2/HO-1 |
| Q37556270 | Cyanate-Impaired Angiogenesis: Association With Poor Coronary Collateral Growth in Patients With Stable Angina and Chronic Total Occlusion |
| Q38773023 | Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy |
| Q50001638 | Features and regulation of non-enzymatic post-translational modifications |
| Q57176511 | Gut Microbiota and Cardiovascular Uremic Toxicities |
| Q91646668 | Hypoxia-Induced Degenerative Protein Modifications Associated with Aging and Age-Associated Disorders |
| Q50321197 | Impact of fibrinogen carbamylation on fibrin clot formation and stability |
| Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
| Q90225367 | Klotho: A Major Shareholder in Vascular Aging Enterprises |
| Q42110772 | Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis |
| Q90439293 | Measurement of Homocitrulline, A Carbamylation-derived Product, in Serum and Tissues by LC-MS/MS |
| Q48010750 | Mechanisms and consequences of carbamoylation |
| Q28074264 | Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins |
| Q33806547 | Molecular and phenotypic biomarkers of aging |
| Q47676591 | Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease |
| Q92561677 | Proteasome-dependent degradation of intracellular carbamylated proteins |
| Q55128365 | Protein Carbamylation: A Marker Reflecting Increased Age-Related Cell Oxidation. |
| Q42676562 | Proteins and their modifications in a medieval mummy |
| Q26748996 | Role of Myeloperoxidase in Patients with Chronic Kidney Disease |
| Q35780015 | The ɛ-Amino Group of Protein Lysine Residues Is Highly Susceptible to Nonenzymatic Acylation by Several Physiological Acyl-CoA Thioesters |
Search more.